晚期NSCLC：退伍军人的最优治疗.pptVIP

EGFR, epidermal growth factor receptor; TKI, tyrosine kinase inhibitor * * * 不能手术的患者，不良预后表现为状态不佳、体重减轻超过10%、男性社会性别 年龄不影响生存和治疗 * * * * * * * * * * BAC, bronchioloalveolar carcinoma 肺泡癌; LPA, lepidic predominant adenocarcinoma 胚层为主的腺癌; NOS; not otherwise specified 未作分型的; SCC, squamous cell carcinoma鳞癌; SCLC, small cell lung cancer小细胞癌; * * BPC, bevacizumab plus carboplatin and paclitaxel; HR, hazard ratio; NSCLC, non-small cell lung cancer; OS, overall survival; PC, paclitaxel and carboplatin * * CG, cisplatin plus gemcitabine; CP, cisplatin plus pemetrexed; NSCLC, non-small cell lung cancer; O